Archived
This content is available here strictly for research, reference, and/or recordkeeping and as such it may not be fully accessible. If you work or study at University of Kentucky and would like to request an accessible version, please use the SensusAccess Document Converter.
Abstract
OBJECTIVE: To determine clinical and neuropathological outcomes following a clinical diagnosis of mild cognitive impairment (MCI).
METHODS: Data were drawn from a large autopsy series (N = 1,337) of individuals followed longitudinally from normal or MCI status to death, derived from 4 Alzheimer Disease (AD) Centers in the United States.
RESULTS: Mean follow‐up was 7.9 years. Of the 874 individuals ever diagnosed with MCI, final clinical diagnoses were varied: 39.2% died with an MCI diagnosis, 46.8% with a dementia diagnosis, and 13.9% with a diagnosis of intact cognition. The latter group had pathological features resembling those with a final clinical diagnosis of MCI. In terms of non‐AD pathologies, both primary age‐related tauopathy (p < 0.05) and brain arteriolosclerosis pathology (p < 0.001) were more severe in MCI than cognitively intact controls. Among the group that remained MCI until death, mixed AD neuropathologic changes (ADNC; ≥1 comorbid pathology) were more frequent than “pure” ADNC pathology (55% vs 22%); suspected non‐Alzheimer pathology comprised the remaining 22% of cases. A majority (74%) of subjects who died with MCI were without “high”‐level ADNC, Lewy body disease, or hippocampal sclerosis pathologies; this group was enriched in cerebrovascular pathologies. Subjects who died with dementia and were without severe neurodegenerative pathologies tended to have cerebrovascular pathology and carry the MCI diagnosis for a longer interval.
INTERPRETATION: MCI diagnosis usually was associated with comorbid neuropathologies; less than one-quarter of MCI cases showed "pure" AD at autopsy. Ann Neurol 2017;81:549-559.
Document Type
Article
Publication Date
4-2017
Digital Object Identifier (DOI)
https://doi.org/10.1002/ana.24903
Funding Information
SMART is supported by NIA grant R01-AG038651 (R. Kryscio and F. Schmitt co-PIs). Cohort studies were supported by NIA grants P30-AG10161 and R01-AG15819 (ROS), R01-AG17917 (Rush MAP), P30-AG028383 (BRAiNS/UK-ADC), P50-AG005681 (Wash U MAP), P30-AG008017 (OBAS, KEAP, AADAPt). Additional support came from R01 NS014189.
Repository Citation
Abner, Erin L.; Kryscio, Richard J.; Schmitt, Frederick A.; Fardo, David W.; Moga, Daniela C.; Ighodaro, Eseosa T.; Jicha, Gregory A.; Yu, Lei; Dodge, Hiroko H.; Xiong, Chengjie; Woltjer, Randall L.; Schneider, Julie A.; Cairns, Nigel J.; Bennett, David A.; and Nelson, Peter T., "Outcomes after Diagnosis of Mild Cognitive Impairment in a Large Autopsy Series" (2017). Epidemiology and Environmental Health Faculty Publications. 70.
https://uknowledge.uky.edu/epidemiology_facpub/70
Supp tables
Included in
Biostatistics Commons, Epidemiology Commons, Neurology Commons, Neurosciences Commons, Pathology Commons, Pharmacy and Pharmaceutical Sciences Commons
Notes/Citation Information
Published in Annals of Neurology, v. 81, issue 4.
© 2017 American Neurological Association
This is the peer reviewed version of the following article: Abner, E. L., Kryscio, R. J., Schmitt, F. A., Fardo, D. W., Moga, D. C., Ighodaro, E. T., Jicha, G. A., Yu, L., Dodge, H. H., Xiong, C., Woltjer, R. L., Schneider, J. A., Cairns, N. J., Bennett, D. A., & Nelson, P. T. (2017). Outcomes after diagnosis of mild cognitive impairment in a large autopsy series: Outcomes of MCI. Annals of Neurology, 81(4), 549–559, which has been published in final form at https://doi.org/10.1002/ana.24903. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Version.